Synthetic lipopeptide adjuvants and Toll-like receptor 2—structure–activity relationships
- 23 June 2004
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 22 (19), 2494-2499
- https://doi.org/10.1016/j.vaccine.2003.11.074
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Evaluation of a Lipopeptide Immunogen as a Therapeutic in HIV Type 1-Seropositive IndividualsAIDS Research and Human Retroviruses, 2000
- Induction of an epitope-specific humoral immune response by lipopeptide–hapten conjugates: enhancement of the anti-melittin response by a synthetic T helper (Th)-cell epitopeFEMS Immunology & Medical Microbiology, 1997
- Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptidesVaccine, 1996
- Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccineJAMA, 1994
- Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activatorVaccine, 1989
- Lipopeptide Derivatives of Bacterial Lipoprotein Constitute Potent Immune Adjuvants Combined with or Covalently Coupled to Antigen or HaptenBiological Chemistry Hoppe-Seyler, 1989
- Cytochrome subunit of the photosynthetic reaction center from Rhodopseudomonas viridis is a lipoproteinBiochemistry, 1987
- Covalent lipoprotein from the outer membrane of escherichia coliBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1975
- The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen.The Journal of Experimental Medicine, 1975